Lawrence Finkel, MD
Dermatology · Warrenton, VANPI 1922065424
Payments from drug & device makers
Across 231 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$790
- Pfizer$547
- Novartis$419
- Lilly USA, LLC$367
- UCB, Inc.$290
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,73394%
- Education$3046%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 44 | $1,091 |
| AbbVie(2 entities) | 37 | $790 |
| Pfizer | 31 | $547 |
| Novartis | 20 | $419 |
| Lilly USA, LLC | 16 | $367 |
| UCB, Inc. | 11 | $290 |
| LEO Pharma Inc. | 7 | $212 |
| Sun Pharmaceutical Industries Inc. | 9 | $193 |
| E.r. Squibb & Sons, L.L.C. | 8 | $189 |
| Galderma Laboratories, L.p. | 7 | $114 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $93 |
| Sanofi | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Incyte Corporation | 4 | $71 |
| EPI Health, LLC | 4 | $66 |
| Amgen | 2 | $56 |
| Organon | 2 | $53 |
| Sandoz | 2 | $44 |
| Mayne Pharma Commercial LLC | 2 | $42 |
| Almirall LLC | 2 | $42 |
| Dermira, Inc. | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 2 | $31 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $29 |
| Boehringer Ingelheim | 1 | $23 |
| Merz North America, Inc. | 1 | $23 |
| Merck | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
How this compares
$5,036 in reported general payments places this provider in the 65th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $84,782 |
| Clobetasol Propionate | 69 | $3,908 |
| Ketoconazole | 61 | $1,777 |
| Imiquimod | 54 | $1,128 |
| Mometasone Furoate | 38 | $918 |
| Fluocinonide | 17 | $782 |
| Triamcinolone Acetonide | 79 | $659 |
| Doxycycline Monohydrate | 29 | $525 |
| Doxycycline Hyclate | 20 | $445 |
| MethotrexateMethotrexate Sodium | 18 | $276 |
| Glycopyrrolate | 11 | $268 |
| Hydrocortisone | 39 | $159 |
| Terbinafine Hcl | 17 | $134 |
| Mupirocin | 16 | $98 |
| Cephalexin | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Warrenton
- Juan Carlos CaballeroWarrenton$14K
- David PariserNorfolk$7M
- Jennifer DesimoneFairfax$2.3M
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Vishal PatelLeesburg$1.1M
- Diego DasilvaVirginia Beach$1.1M
- Carrie CobbLynchburg$859K
- Yvonne KnightRichmond$857K
- David BrayAlexandria$799K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.